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Background: Subjective cognitive impairments are frequent, but poorly understood in
patients with chronic fatigue. We hypothesized that maladaptive metacognitive beliefs
at baseline were associated with baseline subjective cognitive impairments, that they
predict subjective cognitive impairments at treatment termination, and that a reduction
in maladaptive metacognitive beliefs was associated with less subjective cognitive
impairments at treatment termination, independent of changes in fatigue, pain, insomnia,
depression, and anxiety.
Methods: In this non-controlled study, patients (n = 137) on sick leave due
to chronic fatigue received a 3.5-week inpatient RTW rehabilitation program. Of
these patients 69 (50.4%) was referred with a ICPC-2 diagnosis of chronic fatigue.
Patients completed questionnaires about metacognitive beliefs, somatic complaints,
psychological complaints, and cognitive impairments before and after treatment. To test
the hypotheses we performed paired t-tests of change, as well as seven hierarchical
linear regressions.
Results: Results showed that baseline maladaptive metacognitive beliefs were
significantly associated with subjective cognitive impairments at baseline, controlling
for symptoms. Score on baseline metacognitive beliefs did not predict impairments
post-treatment. Testing specific maladaptive beliefs, pre-treatment scores on cognitive
confidence were associated with subjective cognitive impairments both pre and post-
treatment, controlling for symptoms. Post-treatment metacognitive beliefs and post-
treatment cognitive confidence were associated with post-treatment subjective cognitive
impairments, controlling for pre-treatment impairments and pre-treatment metacognitive
beliefs, as well as pre and post-scores on symptom measures.
Conclusion: This study reports associations between maladaptive metacognitive
beliefs and subjective cognitive impairments in patients with chronic fatigue. Targeting
metacognitive beliefs could prove an effective therapeutic intervention for subjective
cognitive impairments in these patients.
Keywords: metacognition, chronic fatigue, memory, attention
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INTRODUCTION
Chronic fatigue syndrome (CFS) is a prevalent condition
characterized by persistent mental and somatic fatigue (Loge
et al., 1998; McCrone et al., 2003). Unfortunately, little ground
has been made when it comes to understanding its etiology,
agreeing on a case definition, or providing patients with
efficacious treatments (Castell et al., 2011). This has led to
symptom measures often being argued as the best way to
classify and investigate these patients (Brurberg et al., 2014).
One of several criteria for fulfilling a CFS case definition is
reporting problems with forgetfulness, increased distractibility,
and reduced mental alertness (Fukuda et al., 1994; Jason et al.,
2004). These subjective cognitive complaints or impairments are
part of all popular CFS classifications (Holmes et al., 1988; Sharpe
et al., 1991) making them a hallmark of the disorder (Jason et al.,
2004). Their importance is underlined by 90% of CFS patients
rating problems with memory and concentration as a primary
concern (Jason et al., 1999).
Memory and concentration are cognitive capabilities
usually defined within the overarching term “executive control
functioning” (Miyake and Friedman, 2012). Executive control
includes many aspects such as the control of attention, the
capacity to access and manipulate information in long-term
memory, as well as monitoring current internal and external
states (Funahashi, 2001). CFS patients report a perceived
inability to perform cognitive tasks and some data indicates
that CFS patients have a lowered performance on objective
neuropsychological tests (Michiels and Cluydts, 2001). However,
this objective bias appears to only be present when the tasks
are highly demanding (Dobbs et al., 2001; Cook et al., 2007).
As an example, performance differences between CFS patients
and controls are reported on the modified Paced Auditory Serial
Attention Test, but not for a simple number recognition task
(Cook et al., 2007). Subjective cognitive impairments on the
other hand, are consistently reported (Cockshell and Mathias,
2014).
Performing demanding cognitive tasks causes mental fatigue
(Cook et al., 2007), which here refers to temporary depletion of
cognitive resources. Within CFS, mental fatigue has documented
effects on attention, working memory, and other executive
control processes (Boksem and Tops, 2008). Hence, evaluation
of predicted rewards and costs quickly becomes relevant. Most
of us tend to loose motivation to perform when the energy costs
are believed to outweigh rewards (Boksem and Tops, 2008). This
means that a subjective cost-benefit analysis of mental fatigue, or
subjective impairment, could affect patients’ objective ability to
efficiently attend to, store and retrieve information when solving
mental tasks.
However, such linking of subjective and objective cognitive
functioning in CFS is controversial and not straightforward
(Cockshell and Mathias, 2014). The foremost example of this
is lack of a consistent correlation between tests (Wearden
and Appleby, 1997), and that both objective performance and
perceived problems could be a result of, or influenced by,
co-morbid symptoms such as pain, insomnia, depression, and
anxiety (Cockshell and Mathias, 2014). A recent review argues
that subjective and objective measures of cognitive complaints
could in fact represent entirely different constructs in these
patients (Cockshell and Mathias, 2014).
Subjective cognitive evaluation can be argued as a form of
metacognitive monitoring (Shimamura, 2000). The concept
of metacognitions has become increasingly popular in
psychotherapy research, also within CFS (Fernie et al., 2015).
Metacognitions are popularly defined as “beliefs about thinking”
or “cognitions about cognition” (Wells, 2011), andmetacognitive
theory is concerned with excessive, sustained verbal thinking,
and dwelling on negative emotions or symptoms in the form
of rumination and/or worry (Nolen-Hoeksema, 2000; Wells,
2011). It is a novel perspective associated with symptom severity
(Fernie et al., 2015), but targets “perception of” and “dwelling
on” symptoms rather than objective changes to metabolism or
nociception. Hence, intervening on metacognitions might offer
a new treatment approach, especially when it comes to subjective
cognitive evaluation.
This notion is substantiated by rumination and worry being
cognitive processes associated with increased mental fatigue
(Querstret and Cropley, 2012). Moreover, excessive worry and
rumination creates andmaintains a specific attention bias toward
threats (Nolen-Hoeksema, 2000; Maren, 2007; Browning et al.,
2010). This bias has within metacognitive theory been coined
the “cognitive attentional syndrome” (CAS; Wells, 2011). It is
there described as a metacognitive process, which maintains and
exacerbates depression and anxiety. However, the CASmay prove
relevant in CFS as well (Maher-Edwards et al., 2011; Fernie
et al., 2015), especially considering data showing CFS patients
interpreting more bodily sensations as sign of physical disease,
compared to depressed and healthy controls (Dendy et al., 2001).
Moreover, a study investigating such selective attention show
CFS patients having a significant bias toward health-threatening
information (Hou et al., 2008).
The theoretical model outlining the development and
maintenance of CAS is the Self-Regulatory Executive Function
(S-REF) model (Wells and Matthews, 1996; Wells, 2011). This
model provides a conceptualization of how metacognitive and
cognitive factors could be involved in the top-down control
of disorders. A central premise in this model is that all
individuals have positive and negative beliefs about thinking
that influences their appraisals (e.g., “I must worry in order
to be prepared” or “I cannot control my thoughts”). Another
premise is that we have implicit procedural metacognitions or
“thinking skills” such as heuristics that influence and shape both
our cognition and behavior (Wells and Matthews, 1996; Wells,
2011).
Investigating subjective cognitive impairments in chronic
fatigue and whether these are associated with dysfunctional
metacognitive beliefs, may further our understanding and
treatment of these complaints. As of now, there are no studies
investigating this association, but one study showcased the
potential relevance of maladaptive metacognitive beliefs in
patients with CFS (Fernie et al., 2015).
It is particularly interesting to see if maladaptive
metacognitive beliefs are associated with subjective cognitive
complaints independent of symptoms. Subjective cognitive
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impairments have previously been reported to predict quality of
life and function in CFS, irrespective of co-morbid symptoms
(Ray et al., 1997).
Testing the independent effect of metacognitions is also
important for treatment development. Several promising
treatment manuals for metacognitive therapy exist, which could
easily be adapted to fit CFS, either as a stand-alone therapy, or
as an addition to graded exercise therapy or traditional cognitive
therapy. Thus, an investigation of metacognitive beliefs and their
association to subjective cognitive complaints in patients with
chronic fatigue is warranted.
The main aim of this study is to investigate the association
of metacognitive beliefs to subjective cognitive impairments
in a population reporting chronic fatigue. We hypothesize
that maladaptive metacognitive beliefs are associated with
subjective cognitive impairments at baseline, controlling for
symptoms of fatigue, pain, insomnia, depression, and anxiety.
Moreover, we hypothesize that maladaptive metacognitive beliefs
at the start of treatment will predict subjective cognitive
impairments at treatment end. We also hypothesize that a
reduction in maladaptive metacognitive beliefs during treatment
is associated with less subjective cognitive impairments at
treatment termination, controlling for the aforementioned
symptoms.
METHODS
Setting and Participants
This study had a pre-post design and was conducted between
January 2012 and June 2013 through a 3, 5-week in-patient,
Return-To-Work (RTW) occupational rehabilitation program
at Hysnes Rehabilitation Center, St. Olav’s University Hospital,
Trondheim, Norway. In Norway a work week includes working
Monday through Friday, or 5 days of work of 7, 5 h each. A
work week is then 37, 5 h in total. Since the program lasted
3 work weeks and 2 work days, it consisted of a total of 17,
7, 5-h workdays during which there was an active intervention
from the institution. The intervention was shaped this way to
emulate a normal work week making the transition to work life
easier for the patients. The choice of an inpatient setting for this
program was due to geographical challenges specific to Norway.
However, the treatment delivered did not exceed that of a day-
based outpatient program with regard to hours and available
personnel (total availability and treatment was 6.5 h from 8:30
a.m. to 3:00 p.m.). For details about the intervention see Fimland
et al. (2014).
Prior to the enrolment in this program, the patients had been
referred from their general practitioner and examined by an
outpatient multidisciplinary team consisting of a physician, a
psychologist, and a physiotherapist. This team evaluated whether
the referred patients met the requirements for participating
in the RTW-program, which included, but were not limited
to the inclusion and exclusion criteria for the current study.
Before beginning the rehabilitation program, all patients were
asked to complete different questionnaires through an internet-
administrated self-report survey. At the end of the study, which
coincided with the end of the rehabilitation program, the patients
again answered several questionnaires.
The inclusion criteria for the study were age (18 to 59 years)
and having been on sick leave for at least 8 weeks due to
fatigue. Further, participants should have self-defined goals of
increasing labor participation, to be adequately assessed and
treated beforehand for any specific illnesses, and be able to attend
a rehabilitation program from 8:30 to 3:00 p.m. all weekdays.
The exclusion criteria were severe mental illness (ongoing mania,
psychosis or suicidal ideation), substance abuse and addiction
or pregnancy. Moreover, patients who could not communicate
in Norwegian or who needed 24-h personal assistance were not
eligible.
To be eligible for this study, participants had to report a score
of five or more on the fatigue questionnaire, a cut-off validated
through previous studies of Norwegian adults (Loge et al., 1998).
Moreover, to be included in all the planned steps of analyses,
the patients could not have any missing data on any of the
independent variables or covariates targeted in the subsequent
multivariable analyses. Hence, the study population consisted
of patients meeting these criteria who upon inclusion in the
program gave their informed consent.
The Regional Committee for Ethics in Medical Research
approved this study and it was conducted in accordance
with the declaration of Helsinki. The study was registered in
clinicaltrials.gov (ID: NCT01568970).
The Rehabilitation Program
Details on the rehabilitation program are published elsewhere
(Fimland et al., 2014). In brief, the program used a combination
of group treatment (8 patients per group) and individual
approaches to facilitate rehabilitation. The participants were
organized with activities through 7-h workdays and the
program lasted for a total of 17 workdays with Acceptance and
Commitment Therapy (ACT) as the overarching treatment
model. Therapists targeted three areas of rehabilitation:
mental training, physical training, and work-related problem
solving.
Measures
The participant’s demographics were reported through a
standardized set of questions validated for a large Norwegian
cohort (Holmen et al., 2003), which is also detailed in previous
studies (Jacobsen et al., 2014; Kallestad et al., 2015).
Dependent Variable
Subjective cognitive complaints were reported using The
Everyday Memory Questionnaire-Revised (EMQ) (Royle and
Lincoln, 2008). The EMQ-Revised is a 13-item measure with
two main factors of retrieval and attentional tracking, reduced
from an original 34-item questionnaire (Royle and Lincoln,
2008). Reliability tests on the EMQ have shown a strong internal
reliability, with a Cronbachs’ Alfa score of.89. Each question is
rated on a 5-point scale ranging from A, scored as one—“Once
or less in the last month,” to E, scored as five—“Once or more in
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a day.” These items are summed and give an ordinal scale with a
range of 0 to 64.
Independent Variables and Covariates
The Chalder Fatigue Questionnaire (Chalder et al., 1993) consists
of eleven questions asking about physical and mental fatigue
and is frequently used to measure symptoms in chronic fatigue
patients. Each item has four response categories (0-4), which
are scored bi-modally 0-0-1-1. When scored, the 11 items are
summed and gives each participant a score on a scale of 0–11.
This eleven-item scale has been validated for a Norwegian adult
population with a cut-off on symptom intensity ≥5. Cronbach’s
alpha has been calculated for all items (range 0.88–0.90). Split half
reliability has also been calculated (0.86 and 0.85, respectively)
(Loge et al., 1998).
The Metacognitions Questionnaire-30 (MCQ-30; Wells and
Cartwright-Hatton, 2004) asks about metacognitive beliefs
through 30 items, compromising five subscales: (1) Positive
beliefs about worry (e.g., “Worrying helpsme cope”); (2) Negative
beliefs about uncontrollability and danger of worry (e.g., “When
I start worrying I cannot stop”); (3) Cognitive confidence (e.g.,
“I have a poor memory”); (4) Need to control thoughts (e.g.,
“Not being able to control my thoughts is a sign of weakness”);
(5) Cognitive self-consciousness (e.g., “I pay close attention
to the way my mind works”). Items are scored from 1 to 4
(“do not agree,” “agree slightly,” “agree moderately,” “agree very
much”), and adding up individual subscale items scores the
subscales. Cronbach’s alpha coefficients for these subscales range
from 0.72 to 0.93, with test-retest correlations of: 0.75 (total
score), 0.79 (positive beliefs), 0.59 (uncontrollability/danger),
0.69 (cognitive confidence), 0.74 (need for control), and 0.87
(cognitive self-consciousness; Wells and Cartwright-Hatton,
2004).
The Hospital Anxiety and Depression Scale (HADS)
(Zigmond and Snaith, 1983) asks about symptoms of anxiety
and depression. The fourteen-item scale with each item ranging
from 0 to 3 yields separate scores for anxiety and depression,
which are then summed and used as an ordinal scale. In a review
of HADS in Norwegian adults the correlations between the
two subscales varied from 0.40 to 0.74 (mean 0.56). Cronbach’s
alpha for HADS-A varied from 0.68 to 0.93 (mean 0.83) and
for HADS-D from 0.67 to 0.90 (mean 0.82; Bjelland et al.,
2002).
The Insomnia Severity Index (Bastien et al., 2001; ISI) is a
seven-item questionnaire assessing sleep problems. A 5-point (0–
4) scale, rated difficulties falling asleep, night-time awakenings,
early morning awakenings, impairment of daytime functioning
due to sleep problems, notice ability of impairments, distress or
worry caused by sleep difficulties, and dissatisfaction with sleep.
The items were summed; giving a scale of 0–28, where ≥15
was used as a moderate cut-off indicating sleep problems. This
cut-off has been validated in previous studies and the internal
consistency of the ISI was reported to be 0.74 (Morin et al.,
2011).
Chronic pain was measured with an item from Short Form-8
(Ware et al., 2001) asking “How much bodily pain have you had
the last week?” (None, very mild, mild, moderate, severe, and very
severe). This scale has been validated as a self-report measure
of chronic pain in Norwegian populations. As this is a one-item
measurement, alpha values are not applicable. The item has been
shown to have an intra-class correlation coefficient of 0.66 (95%
CI 0.65 to 0.67; Landmark et al., 2012).
Statistical Analysis
Demographical data from participants was analyzed using
frequencies (dichotomous variables) and means (ordinal
variables) with standard deviations. Paired t-tests were
performed to investigate significant change from pre to post-
treatment on subjective cognitive impairments, maladaptive
metacognitions, insomnia, fatigue, pain, depression, and anxiety.
To test for associations between maladaptive metacognitive
beliefs (MCQ-30) and subjective cognitive impairments at
baseline, we performed two hierarchical linear regression
models: First, using subjective cognitive impairments pre-
treatment as a dependent variable we performed a hierarchical
regression model with two steps. In step one, we entered
participants’ sex and age, and in step two we entered pre-
treatment MCQ-30 sum total score. Then, we performed a
hierarchical linear regression with three steps. In step one,
we entered participants’ sex and age, and in step two we
entered pre-treatment scores on the five symptom measures.
In step three we entered pre-treatment MCQ-30 sum total
score.
Next, we performed a third hierarchical regression model
testing the associations of the five subscales of MCQ-30
(cognitive confidence, need to control thoughts, positive beliefs,
danger/uncontrollability and cognitive consciousness) with
subjective cognitive impairments. In step one, we entered
participants’ sex and age, and in step two we entered pre-
treatment scores on symptommeasures. In step three we entered
pre-treatment scores on cognitive confidence need to control
thoughts, positive beliefs, danger/uncontrollability, and cognitive
consciousness.
To test whether maladaptive metacognitive beliefs (MCQ-30)
at treatment start were associated with subjective cognitive
impairments at treatment termination, we performed a
hierarchical linear regression using subjective cognitive
impairments post-treatment as a dependent variable. In this
regression model we entered sex and age in step one, in step
two we entered pre-treatment values for subjective cognitive
impairments. In step three we entered pre-treatment sum total
scores for MCQ-30.
To test whether a reduction in maladaptive metacognitive
beliefs (MCQ-30) were associated with change in subjective
cognitive impairments, we added fourth step in the hierarchical
linear regression using subjective cognitive impairments at
treatment termination as the dependent variable. We entered sex
and age in step one, in step two we entered pre-treatment scores
for subjective cognitive impairments, in step three we entered
pre-treatment sum total score for MCQ-30. In step four, we
entered the MCQ-30 sum total score at treatment end.
To test whether maladaptive metacognitive beliefs (MCQ-
30) was associated with subjective cognitive impairments (EMQ)
controlling for levels of fatigue, pain, insomnia, depression, and
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anxiety, we performed a hierarchical linear regression using
subjective cognitive impairments at treatment termination as the
dependent variable. We entered sex and age in step one, in step
two we entered pre-scores for EMQ, and in step three we entered
pre-treatment sum total scores on MCQ-30. In step four we
entered pre-treatment scores on the five symptom measures. In
step five we entered post-treatment sum total scores for MCQ-
30 and in step six we entered post-treatment scores on the five
symptom measures.
To test whether the subscales of the maladaptive
metacognitive beliefs (MCQ-30) questionnaire were associated
with subjective cognitive impairments (EMQ) controlling
for levels of fatigue, pain, insomnia, depression, and anxiety,
we performed a hierarchical linear regression using subjective
cognitive impairments at treatment termination as the dependent
variable. We entered sex and age in step one, in step two we
entered pre-scores for EMQ, and in step three we entered
pre-treatment scores on the subscales of MCQ-30. In step four
we entered pre-treatment scores on the five symptom measures.
In step five we entered post-treatment scores on the subscales of
MCQ-30 and in step six we entered post-treatment scores on the
five symptom measures.
All analyses were performed using the Statistical Package
for the Social Sciences (SPSS version 22.0; IBM Corporation,
Armonk, NY, USA). In all regressions we estimated correlations
and colinearity in order to ensure the validity of the models.
RESULTS
Population Demographics
One hundred and eighty-one participants were included in the
current study. Of these 181 participants, 137 had no missing
data, were available for multivariable analysis and t-tests, and
represented the study population. All participants reported
fatigue above the chosen cut off. They were predominantly
female (80.3%) with a mean age of 43.6 (SD 9.4) years, and
with education at a high school level or above (87.6%). For an
overview of participant characteristics, see Table 1. Paired t-tests
of change for subjective cognitive impairments and maladaptive
metacognitive beliefs are presented in Table 2.
Hypothesis 1: Maladaptive Metacognitive
Beliefs are Associated with Subjective
Cognitive Impairments at Baseline
The sum score on maladaptive metacognitive beliefs (MCQ-
30) at baseline was significantly associated with the subjective
cognitive impairments (EMQ) sum score at baseline (p < 0.0001;
t = 4.5; B = 0.34; 95% Confidence Interval of B (CI) = 0.19,
0.49), controlling for sex, age and pre-scores on symptom scales.
Fatigue score pre-treatment (p < 0.0001; t = 6.4; B = 3; CI =
2.1, 3.9) and depression score pre-treatment (p = 0.03; t = −2.2;
B = −0.53; CI = −1, −0.61) were also significantly associated
with EMQ sum score at baseline.
Investigating the subscales of MCQ-30, the subscale of
cognitive confidence (p < 0.0001; t = 8.2; B = 1.4; CI = 1.1, 1.8)
was significantly associated with the EMQ sum score, controlling
TABLE 1 | Characteristics of all included participants (n = 137)
self-reporting clinically significant physical and mental fatigue when
starting inpatient vocational rehabilitation.
Demographics Male Female
Sex (n) 19.7% (27) 80.3% (110)
Age (SD) 41.0 (11.8) 41.1 (9.2)
Height—cm (SD) 180.4 (8.1) 166.8 (5.9)
Weight—kg (SD) 88.3 (15.7) 76.0 (16.4)
BMI (SD) 27.0 (4.0) 27.3 (5.6)
Diagnosed chronic fatigue in ICPC-2: A04 or
P29 (n)
55.6% (15) 49.0% (54)
RELATIONSHIP STATUS (n):
Married/Living with Partner (n) 66.6% (18) 70.6% (79)
Single/Divorced/Widowed (n) 44.4% (9) 29.4% (33)
EDUCATION (n):
Less than High School 18.5% (5) 18.0% (20)
High School 40.7% (11) 35.1% (39)
Some College/University 29.6% (8) 40.5% (45)
Any College/University Degree 11.1% (3) 6.3% (7)
PSYCHIATRIC DIAGNOSES (n):
SCID diagnosed Anxiety disorders
(F40.1 F40.2 F41.0 F41.1 F41.2 F41.9 F45.2)
7.4% (2) 9.7% (11)
SCID diagnosed Depressive disorders
(F32.0 F32.1 F.33.1 F34.1 F43.2)
7.4% (2) 7.1% (8)
Self-reported symptoms above cut-off Male Female
HADS Depression (n) 51.9% (14) 42.9% (48)
HADS Anxiety (n) 55.6% (15) 54.9% (62)
Chronic Pain (n) 59.3% (16) 78.8% (89)
Sleep Problems (n) 33.3% (9) 26.5% (30)
Categorical characteristics are reported as percent (frequency) and ordinal characteristics
as mean (standard deviation). Numbers may not add up to 137 because of missing
data on some characteristics. Percentage is calculated as percentage of total n of the
respective sex (male/female). F43.2 is categorized as a depressive disorder in this table,
however, it could also be classified as an anxiety disorder as it has somewhat overlapping
symptoms. Some participants have two SCID diagnoses and were categorized by the
primary diagnosis.
for pre-treatment symptom scores, as was the pre-score on the
chosen fatigue scale (p < 0.0001; t= 3.6; B= 1.7; CI= 0.77, 2.6).
The subscales of positive beliefs, need to control thoughts, danger
and cognitive consciousness were not. Zero order correlations
between the self-report measures ranged from (−0.2 to 0.6), with
cognitive confidence being the highest and need for thought
control the lowest. Both collinearity tolerance (1.0–0.5) and
variance inflation factor values (1.0–2.4) were acceptable in the
regression model.
Hypothesis 2: Maladaptive Metacognitive
Beliefs Pre-treatment are Associated with
Subjective Cognitive Impairments at
Treatment Termination
A hierarchical regression analysis showed that the pre-treatment
sum total score on MCQ-30 was not associated with EMQ sum
score post-treatment, when controlling for pre-scores on the
EMQ (p= 0.77; t= 0.29; B= 0.17; CI=−0.1, 0.13).
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TABLE 2 | Averaged change on outcomes, metacognitive beliefs, fatigue, mental distress (including insomnia) and pain reported by participants’ pre-post
intervention.
Variable Pre-treatment Post-treatment Paired samples t-test
Mean SD Mean SD t p g
COGNITIVE MEASURES:
Subjective cognitive complaints (EMQ) 30.8 12.3 29.8 12.6 1.4 0.17 0.03
MCQ-30 total 53.8 12.2 51.0 11.2 3.9 < 0.001 0.2
MCQ SUBSCALES:
Cognitive confidence 13.1 4.6 12.1 4.4 3.2 0.002 0.15
Positive beliefs 7.6 2.2 7.3 1.7 1.7 0.1 0.05
Cognitive consci. 11.8 3.4 11.8 3.5 −0.3 0.98 0.2
Uncontrollability 11.0 3.7 11.5 3.8 −2.0 0.05 0.2
Need to control thoughts 9.7 3.1 9.9 3.2 −0.9 0.35 0.2
MENTAL DISTRESS, FATIGUE, AND PAIN:
Insomnia (ISI) 12.2 6.1 9.8 6.4 5.53 < 0.001 0.38
Pain (SF-8) 3.95 1.14 3.5 1.15 4.97 < 0.001 0.39
Depression (HADS) 7.1 3.8 4.9 3.4 8.0 < 0.001 0.65
Anxiety (HADS) 8.2 4.2 6.2 3.8 6.6 < 0.001 0.50
Fatigue (CFQ) 9.0 1.8 5.7 3.9 10.6 < 0.001 1.08
All variables were significance tested with a paired t-test and degree of change was described as a Hedges g effect size.
As pre-treatment cognitive confidence was the only subscale
associated with pre-treatment score on EMQ, we performed
an additional analysis looking specifically at this subscale. Pre-
treatment scores on cognitive confidence were significantly
associated with post-treatment scores on EMQ, controlling for
scores on all symptom measures both pre and post-treatment (p
< 0.0001; t=−3.8; B=−0.7; CI=−1.1,−0.35).
Hypothesis 3: A Reduction in
Metacognitive Beliefs Post-Treatment is
Associated with Less Subjective Cognitive
Complaints at Treatment Termination
Results from a hierarchical regression showed that a reduction
on MCQ-30 was significantly associated with a reduced post-
treatment score on EMQ, controlling for pre-treatment MCQ-
30 scores, fatigue scores (pre-post), pain (pre-post), insomnia
severity (pre-post), anxiety and depression (pre-post) (p <
0.0001; t = 3.6; B = 0.35; CI = 0.16, 0.5). Analytic details of the
regression are presented in Table 3.
As pre-treatment cognitive confidence was associated with
pre-treatment and post-treatment score on EMQ, we again
performed an additional analysis looking specifically at this
subscale. Post-treatment scores on cognitive confidence were
significantly associated with post-treatment scores on EMQ,
controlling for scores on all symptom measures both pre and
post-treatment (p < 0.0001; t= 6.0; B= 1.2; CI= 0.8, 1.7).
DISCUSSION
This is the first study to report associations between maladaptive
metacognitive beliefs and subjective cognitive impairments in
chronically fatigued patients. Maladaptive metacognitive beliefs
were associated with subjective cognitive complaints at baseline.
Investigating the subscales of MCQ-30, only the scale asking
beliefs about cognitive confidence had pre-treatment scores
associated with pre-treatment subjective cognitive impairments.
When looking at whether maladaptive metacognitive beliefs
at baseline predicted subjective impairments at treatment
end, we found that the sum of MCQ-30 did not predict
subjective ratings. However, baseline scores on the subscale
of cognitive confidence did predict subjective impairments
at treatment end. Moreover, when testing if a reduction in
sum total maladaptive metacognitive beliefs predicted less
subjective cognitive impairments at treatment termination, we
found a significant association that remained when controlling
for baseline subjective cognitive complaints, and pre-post
scores on fatigue, pain, insomnia, depression and anxiety.
This was also the case for a reduction in post-treatment
values on the cognitive confidence subscale, indicating that
this subscale is particularly relevant in subjective cognitive
impairments.
Our finding that baseline metacognitive beliefs concerning
cognitive confidence were associated with baseline scores
on subjective cognitive complaints is new. According to
metacognitive theory, metacognitive beliefs about the lack
of cognitive confidence will stop adaptive cognitive coping
strategies when patients are feeling mental fatigue. Indeed,
maladaptive metacognitive beliefs about cognitive confidence
have been previously been associated with symptom severity in
CFS patients (Fernie et al., 2015). It is not unlikely then that
this association with symptom severity is related to patients’
subjective cognitive impairments. This claim is substantiated by
memory evaluations, such as our judgments of learning abilities
being construed as a specific form of metacognitive monitoring
(Shimamura, 2000).
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TABLE 3 | Hierarchical regressions using everyday memory questionnaire
(EMQ) post-treatment as a dependent variable and metacognitive
questionnaire (MCQ) as an independent variable, controlling for
pre-treatment values of EMQ, MCQ, fatigue, pain, insomnia, depressive
symptoms and post-treatment values of fatigue, pain and depressive
symptoms.
Variables Beta P 95% Confidence
Coefficient Interval
Low High
STEP 1:
Sex −0.127 0.165 −9.421 1.628
Age 0.097 0.286 −0.119 0.400
STEP 2:
Sex −0.080 0.142 −5.753 0.838
Age 0.048 0.374 −0.085 0.224
Pre-treatment EMQ 0.798 0.000 0.691 0.906
STEP 3:
Sex −0.080 0.145 −5.761 0.857
Age 0.048 0.375 −0.086 0.225
Pre-treatment EMQ 0.793 0.000 0.678 0.908
Pre-treatment MCQ-30 0.016 0.785 −0.099 0.131
STEP 4:
Sex −2.761 0.125 −6.305 0.783
Age 0.086 0.288 −0.074 0.246
Pre-treatment EMQ 0.775 0.000 0.642 0.907
Pre-treatment MCQ-30 0.050 0.452 −0.081 0.182
Pre-treatment Fatigue 0.068 0.884 −0.850 0.986
Pre-treatment Anxiety −0.204 0.315 −0.603 0.196
Pre-treatment Depression −0.183 0.414 −0.626 0.260
Pre-treatment Pain −0.237 0.707 −1.487 1.012
Pre-treatment Insomnia 0.169 0.189 −0.085 0.424
STEP 5:
Sex −2.337 0.158 −5.597 0.923
Age 0.095 0.204 −0.052 0.242
Pre-treatment EMQ 0.723 0.000 0.600 0.847
Pre-treatment MCQ-30 −0.207 0.014 −0.371 −0.044
Pre-treatment Fatigue 0.145 0.734 −0.699 0.989
Pre-treatment Anxiety −0.185 0.320 −0.552 0.182
Pre-treatment Depression −0.405 0.057 −0.823 0.013
Pre-treatment Pain 0.224 0.704 −0.941 1.389
Pre-treatment Insomnia 0.152 0.200 −0.082 0.385
Post-treatment MCQ-30 0.411 0.000 0.235 0.587
STEP 6:
Sex −2.330 0.162 −5.615 0.954
Age 0.054 0.459 −0.091 0.200
Pre-treatment EMQ 0.728 0.000 0.608 0.849
Pre-treatment MCQ-30 −0.138 0.098 −0.302 0.026
Pre-treatment Fatigue −0.081 0.859 −0.983 0.821
Pre-treatment Anxiety 0.048 0.822 −0.375 0.471
Pre-treatment Depression −0.515 0.030 −0.981 −0.050
Pre-treatment Pain −0.342 0.613 −1.678 0.993
Pre-treatment Insomnia −0.041 0.783 −0.332 0.251
(Continued)
TABLE 3 | Continued
Variables Beta P 95% Confidence
Coefficient Interval
Low High
Post-treatment MCQ-30 0.347 0.000 0.156 0.538
Post-treatment Fatigue 0.197 0.334 −0.205 0.599
Post-treatment Pain 1.350 0.054 −0.026 2.727
Post-treatment Insomnia 0.182 0.239 −0.123 0.487
Post-treatment Anxiety −0.581 0.048 −1.156 −0.006
Post-treatment Depression 0.517 0.095 −0.092 1.125
Everyday memory questionnaire—Revised (EMQ); Metacognitive beliefs questionnaire
(MCQ).
The current results may have interesting clinical implications.
According to recent theorizing in metacognition, cognitive
processes are split into two interrelated levels: the meta-level
and the object level (Wells, 2011). The meta-level contains a
cognitivemodel of the object level, organized according to certain
metacognitive principles. Themeta-level is continuously updated
by bottom-up information, and in return controls the object
level by providing top-down input, initiating and terminating
actions performed by the object level, here understood as
an experience of memory or concentration failure. Thus,
metacognitive regulation is a meta-level system that modulates
cognitive processes at the lower level. It adds flexibility to
cognitive processes, making them less dependent on external
cues (Wells, 2011). Metacognitions also include self-reflection.
The ability to recognize ones own maladaptive behavior and
perpetuation of symptoms through rumination and worry is
an important metacognitive skill (Wells, 2011). Self-reflection
is largely a product of early life experiences (Dimaggio et al.,
2010), and it is difficult to exclude effects from these experiences
in the current study. However, given that one does not
have an adequate metacognitive skill to guide actions when
experiencing fatigue, this could be a marker for increased
risk for developing long-term fatigue. Thus, targeting cognitive
confidence both as a screening in patients initially reporting
fatigue, subsequently targeting it through metacognitive therapy,
could provide us with both a screening tool and a therapeutic
intervention.
Our finding that cognitive confidence at baseline predicted
subjective cognitive complaints at treatment end is also
interesting in this regard. Previous data have shown that CFS
patient’s objective cognitive abilities will vary over a span
of 10 weeks (Fuentes et al., 2001). It is perhaps indicated
here that subjective cognitive evaluations are more stable
constructs and therefore a more apt target for intervention.
The current results suggest that an intervention on maladaptive
metacognitions about cognitive confidence would positively
influence subjective evaluations over time. This would potentially
alleviate a concern that 90% of CFS patients rate as primary and
debilitating.
The main finding in this study was that a reduction in
dysfunctional metacognitive beliefs during treatment was
associated with less subjective cognitive impairments at
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treatment termination. This relationship was not affected by
symptoms of fatigue, pain, insomnia, anxiety or depression.
Previous studies have attributed subjective cognitive
impairments in CFS to the level of depressive symptoms
in patients (Wearden and Appleby, 1997; Cockshell and
Mathias, 2014). While depressive symptoms and anxiety also
showed a significant association with subjective cognitive
complaints in the current study population, they did not
influence the unique association with maladaptive metacognitive
beliefs.
However, the reported relationship between depressive
symptoms, anxiety, and subjective cognitive complaints does
add a second argument for investigating metacognitions further.
Metacognitive therapy has previously shown promising results
with depressed patients lacking success from traditional cognitive
behavioral therapy (CBT; Wells et al., 2012). Lack of success with
CBT is also the case for many chronic fatigue patients (Castell
et al., 2011), and metacognitive therapy could be a feasible option
for such cases. Moreover, metacognitions have been argued as
highly relevant in the development and maintenance of general
anxiety disorder (Wells, 2005), a diagnosis often comorbid with
CFS (Fischler et al., 1997).
Of particular relevance to the current results is a recent
text comparing subjective vs. objective cognitive impairment in
chronic fatigue syndrome (Cockshell and Mathias, 2014). The
authors argue that these are different concepts entirely. It seems
that subjective impairment is somewhat imprecise and more
generic, while objective impairments are closely linked to task
difficulty (Cockshell and Mathias, 2014).
Considering this, it is tempting to further speculate on how
subjective cognitive complaints could be a prime target for
intervention. Perseverative thinking in the form of subjective
cognitive complaints may lead to physiological changes
or prolonged activation, and that in turn might change
the patients experience of fatigue and/or disrupt recovery
(Brosschot et al., 2006). Current stress theory argues that by
targeting such perseverative thinking, we might be able to
ameliorate not only subjective cognitive complaints, but also the
intensity and frequency of fatigue symptoms (Brosschot et al.,
2006).
It is important to note that this study used an ACT
intervention, not metacognitive therapy. While our results
imply that targeting metacognitive beliefs through metacognitive
therapy is perhaps not necessary to change them, it does not
answer whether using a therapy specifically focused on changing
metacognitive beliefs could increase this change. The reported
change in this study is minor, and it could very well be that a
targeted metacognitive therapy would have made more impact
on the patients’.
LIMITATIONS
The current study has some limitations, the foremost being
the lack of a control group. Another limitation is that
outcome variables are based on self-report and not clinical
or objective evaluations. Self-reported fatigue on the Chalder
Fatigue Questionnaire was used as a cut-off for fatigue, opposed
to a clinical examination, semi-structured interviews or fitness
tests. Thus, the participants’ results may not be generalizable
to the group of patients who meet the full diagnostic criteria
for CFS. However, the mean pre-treatment scores on Chalder
Fatigue Scale are in line with other studies of patients with
diagnosed CFS (White et al., 2011), and systematic reviews
have argued that symptom measures are the best way to
evaluate interventions in chronic fatigue (Brurberg et al., 2014).
We did not have data on menopause/perimenopause status
in our particpants, which could be considered a limitation
since this can affect variables measured. It is also a limitation
that subjective cognitive impairments were assessed by a
questionnaire not an semi-structured interview, however, this
is a common way of estimating such impairments. Moreover,
with approximately 10% of participants reporting an emotional
disorder on SCID-I, this might influence the data on maladaptive
metacognitions, as these are prevalent in anxiety and depression.
Finally, it is a limitation that 27% of patients’ were excluded
because of missing data, and this may have influenced our
results.
CONCLUSION
This non-controlled study reports significant associations
between dysfunctional metacognitive beliefs and subjective
cognitive impairments in chronically fatigued patients. These
associations highlight the potential importance of targeting
maladaptive metacognitive beliefs in chronic fatigue. Finally,
our results give cause to investigate metacognitive therapy
as a potential supplemental or novel psychological treatment
for CFS.
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